STAT6 silencing induces hepatocellular carcinoma-derived cell apoptosis and growth inhibition by decreasing the RANKL expression

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Tian QingShen Zhongyang

Abstract

Signal transducer and activator of transcription-6 (STAT6) is highly expressed in various human cancers and considered a regulator of multiple biological processes in cancers, including cell apoptosis. Evidence has indicated that STAT6 predicts a worse prognosis in hepatocellular carcinoma (HCC) patients. The objective of this study was to investigate the effects and mechanism of STAT6 in human HCC cells. We found that STAT6 silencing significantly inhibited HepG2 and Hep3B cell survival and proliferation. We observed that depletion of STAT6 increased HepG2 and Hep3B cell apoptosis by using a histone DNA ELISA detection kit. STAT6 silencing induced expression of apoptosis-associated genes Bax and caspase-3/7 and inhibited anti-apoptosis gene Bcl-2 levels. We also observed that STAT6 silencing downregulated the expression of receptor activator of NF-κB ligand (RANKL). Our results demonstrated that treatment with pcDNA3.1-RANKL abolished STAT6 depletion-induced HepG2 and Hep3B cell apoptosis and growth inhibition. Based on these findings, we believe that RANKL plays a major role in STAT6-induced HCC cell apoptosis.

References

Aug 12, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A KatoA B Lentsch
Jun 26, 2002·Neoplasia : an International Journal for Oncology Research·Jennifer L GoochDouglas Yee
Sep 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Barbara JarugaBin Gao
Oct 11, 2005·Critical Reviews in Oncology/hematology·Heather A Bruns, Mark H Kaplan
May 19, 2010·World Journal of Gastroenterology : WJG·Cheng-Gang WangShan Wang
Dec 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Roberto R Ricardo-GonzalezAjay Chawla
Oct 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nozomu SakaiAlex B Lentsch
Feb 14, 2012·Biochemical and Biophysical Research Communications·Harunori TakeshitaHajime Sano
Apr 13, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Mariana Kiomy OsakoRyuichi Morishita
Aug 21, 2013·Free Radical Biology & Medicine·Seungha HyeonWoojin Jeong
Feb 5, 2014·Biochemical and Biophysical Research Communications·Dachuang LiuMing Chen
Jun 20, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elisabeth MaierJutta Horejs-Hoeck
Mar 11, 2015·Biochemical and Biophysical Research Communications·Heyuan DingYiming Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.